GeneFerm Biotechnology Co., Ltd. (TPEX:1796)
Taiwan · Delayed Price · Currency is TWD 34.40
-3.80 (-9.95%)
At close: Jul 9, 2026
GeneFerm Biotechnology Market Cap
GeneFerm Biotechnology has a market cap or net worth of 1.43 billion as of July 9, 2026. Its market cap has decreased by -24.06% in one year.
Market Cap
1.43B
Enterprise Value
1.47B
Revenue
663.87M
Ranking
n/a
PE Ratio
90.84
Stock Price
34.40
Market Cap Chart
Since July 26, 2016, GeneFerm Biotechnology's market cap has decreased from 2.17B to 1.43B, a decrease of -34.40%. That is a compound annual growth rate of -4.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 1.43B | -28.70% |
| Dec 31, 2025 | 2.00B | 2.66% |
| Dec 31, 2024 | 1.95B | -36.91% |
| Dec 29, 2023 | 3.09B | 11.36% |
| Dec 30, 2022 | 2.77B | 53.32% |
| Dec 30, 2021 | 1.81B | 122.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PhytoHealth | 2.48B |
| Allied Biotech | 2.38B |
| Johnson Chemical Pharmaceutical Works | 2.23B |
| TSH Biopharm Corporation | 1.95B |
| InnoPharmax | 1.31B |
| Excelsior Biopharma | 1.12B |
| Prince Pharmaceutical | 1.11B |
| Winston Medical Supply | 1.11B |